Multiple investigational agents have been developed and are being studied.
Nancy B. Davis, MD
Advertisement
Davis is an associate professor of medicine and urology and vice president for Cancer Care Network and Strategy at Vanderbilt University Medical Center, Nashville, Tennessee.
Articles by Nancy B. Davis, MD
Advertisement
Latest Updated Articles
BCG-unresponsive NMIBC: Current evidence and optionsPublished: November 24th 2021 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer
5
